Pages that link to "Q43823539"
Jump to navigation
Jump to search
The following pages link to Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. (Q43823539):
Displaying 50 items.
- Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit (Q21194915) (← links)
- Invasive candidiasis as a cause of sepsis in the critically ill patient (Q22305429) (← links)
- Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients (Q24186457) (← links)
- Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients (Q24244555) (← links)
- Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality (Q24530412) (← links)
- Canadian practice guidelines for surgical intra-abdominal infections (Q24599288) (← links)
- Epidemiological trends in nosocomial candidemia in intensive care (Q25255762) (← links)
- Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later (Q27012454) (← links)
- Fluconazole pharmacokinetics and safety in premature infants (Q27014816) (← links)
- Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients (Q28362691) (← links)
- Epidemiology of invasive candidiasis: a persistent public health problem (Q29616758) (← links)
- Invasive candidiasis: from mycobiome to infection, therapy, and prevention (Q30251428) (← links)
- SSD1 is integral to host defense peptide resistance in Candida albicans (Q33339288) (← links)
- Effect of antifungal therapy timing on mortality in cancer patients with candidemia (Q33559164) (← links)
- An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis (Q33735943) (← links)
- Role of newer azoles in surgical patients (Q33840089) (← links)
- Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America (Q33894467) (← links)
- Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. (Q33943521) (← links)
- Emerging issues in antibiotic resistance in blood-borne infections (Q34078706) (← links)
- Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective). (Q34170333) (← links)
- Prophylactic antifungal therapy in the intensive care unit (Q34205622) (← links)
- Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor (Q34230759) (← links)
- Epidemiology of Candida species infections in critically ill non-immunosuppressed patients (Q34273626) (← links)
- Management of Candida species infections in critically ill patients (Q34280580) (← links)
- Antifungal clinical trials and guidelines: what we know and do not know (Q34400255) (← links)
- The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis (Q34480715) (← links)
- Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? (Q34490092) (← links)
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (Q34505582) (← links)
- Therapeutic dilemma of fluconazole prophylaxis in intensive care (Q34509391) (← links)
- Pharmacotherapy of Candida bloodstream infections: new treatment options, new era. (Q34768471) (← links)
- Fluconazole loading dose pharmacokinetics and safety in infants (Q34807770) (← links)
- The Pathophysiology and Treatment of Candida Sepsis (Q34848032) (← links)
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (Q34936576) (← links)
- Invasive candidiasis in non-hematological patients (Q35010671) (← links)
- Deeply invasive candidiasis (Q35038450) (← links)
- Management of invasive candidiasis in nonneutropenic ICU patients (Q35122093) (← links)
- Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients (Q35125400) (← links)
- How much European prescribing physicians know about invasive fungal infections management? (Q35131938) (← links)
- Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis (Q35162610) (← links)
- Diagnosis of invasive candidiasis in the ICU. (Q35574038) (← links)
- New approaches to the risk of Candida in the intensive care unit (Q35587111) (← links)
- Prophylaxis and treatment of invasive candidiasis in the intensive care setting (Q35889819) (← links)
- Management of invasive candidiasis in critically ill patients (Q35904821) (← links)
- Fluconazole for the treatment of candidiasis: 15 years experience (Q35917407) (← links)
- Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions (Q35960005) (← links)
- Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment (Q36001726) (← links)
- Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study (Q36070524) (← links)
- Risk factors for invasive fungal disease in critically ill adult patients: a systematic review (Q36073057) (← links)
- Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? (Q36073196) (← links)
- Antifungal chemotherapeutics (Q36111677) (← links)